

A personalized mRNA cancer vaccine for melanoma is showing clinical success, offering hope that cancer treatment breakthroughs might help rebuild public confidence in vaccine technology.

The same mRNA platform that powered COVID-19 vaccines is now being adapted to fight cancer.

Want to know more?